Precise Biometrics AB (PBC) Ratios
Precise Biometrics AB Ratios
DE:PBC's free cash flow for Q2 2026 was $3.24M. For the 2026 fiscal year, DE:PBC's free cash flow was decreased by $-62.00K and operating cash flow was $3.30M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.37 | 1.90 | 2.05 | 1.57 | 1.30 |
| Quick Ratio | 1.36 | 1.89 | 2.04 | 1.56 | 1.29 |
| Cash Ratio | 0.59 | 1.06 | 1.32 | 1.12 | 0.88 |
| Solvency Ratio | 0.01 | 0.28 | -0.03 | -0.02 | -0.09 |
| Operating Cash Flow Ratio | 0.06 | 0.28 | -0.30 | 0.09 | -0.02 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -612.00K | $ 15.78M | $ 20.12M | $ -1.69M | $ -18.89M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.13 | 0.02 | 0.15 | 0.03 |
| Debt-to-Equity Ratio | 0.08 | 0.17 | 0.03 | 0.22 | 0.06 |
| Debt-to-Capital Ratio | 0.08 | 0.15 | 0.03 | 0.18 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.33 | 1.34 | 1.33 | 1.46 | 1.88 |
| Debt Service Coverage Ratio | 5.49 | 38.20 | -1.35 | 0.07 | -42.13 |
| Interest Coverage Ratio | -27.96 | -24.39 | -26.46 | -5.86 | -63.11 |
| Debt to Market Cap | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.15 | 0.33 | 0.08 | 0.76 | 0.19 |
| Net Debt to EBITDA | -2.49 | -0.82 | 25.39 | 13.46 | 6.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 72.82% | 72.61% | 63.71% | 71.45% | 76.26% |
| EBIT Margin | -22.03% | -10.84% | -35.24% | -24.36% | -15.75% |
| EBITDA Margin | 3.88% | 16.58% | -2.26% | -1.12% | -11.16% |
| Operating Profit Margin | -22.03% | -10.84% | -35.24% | -21.99% | -16.89% |
| Pretax Profit Margin | -26.05% | -10.11% | -35.63% | -25.78% | -16.02% |
| Net Profit Margin | -25.60% | -9.71% | -35.17% | -24.42% | -16.14% |
| Continuous Operations Profit Margin | -25.60% | -9.71% | -35.17% | -24.42% | -16.14% |
| Net Income Per EBT | 98.29% | 96.00% | 98.71% | 94.72% | 100.73% |
| EBT Per EBIT | 118.27% | 93.31% | 101.10% | 117.25% | 94.86% |
| Return on Assets (ROA) | -11.44% | -4.15% | -12.42% | -10.43% | -5.58% |
| Return on Equity (ROE) | -15.21% | -5.58% | -16.57% | -15.19% | -10.50% |
| Return on Capital Employed (ROCE) | -11.97% | -5.62% | -14.97% | -11.66% | -8.35% |
| Return on Invested Capital (ROIC) | -11.60% | -5.32% | -14.58% | -10.92% | -8.27% |
| Return on Tangible Assets | -36.60% | -10.77% | -33.04% | -29.91% | -12.74% |
| Earnings Yield | -11.04% | -2.18% | -36.61% | -11.59% | -2.35% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.69 | 3.22 | 3.92 | 0.00 | 3.47 |
| Payables Turnover | 8.75 | 10.34 | 10.01 | 4.37 | 1.96 |
| Inventory Turnover | 76.34 | 98.29 | 75.89 | 83.54 | 36.09 |
| Fixed Asset Turnover | 6.51 | 8.16 | 11.64 | 10.01 | 7.27 |
| Asset Turnover | 0.45 | 0.43 | 0.35 | 0.43 | 0.35 |
| Working Capital Turnover Ratio | 3.57 | 2.49 | 2.45 | 4.02 | 1.97 |
| Cash Conversion Cycle | 62.09 | 81.60 | 61.57 | -79.25 | -70.58 |
| Days of Sales Outstanding | 99.02 | 113.20 | 93.22 | 0.00 | 105.26 |
| Days of Inventory Outstanding | 4.78 | 3.71 | 4.81 | 4.37 | 10.11 |
| Days of Payables Outstanding | 41.70 | 35.31 | 36.47 | 83.61 | 185.95 |
| Operating Cycle | 103.80 | 116.91 | 98.03 | 4.37 | 115.37 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.13 | -0.16 | 0.08 | -0.04 |
| Free Cash Flow Per Share | 0.01 | -0.02 | -0.40 | -0.38 | -0.51 |
| Dividend Paid and CapEx Coverage Ratio | 1.52 | 0.89 | -0.70 | 0.18 | -0.08 |
| Capital Expenditure Coverage Ratio | 1.52 | 0.89 | -0.70 | 0.18 | -0.08 |
| Operating Cash Flow Coverage Ratio | 0.18 | 0.39 | -2.38 | 0.12 | -0.20 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.12 | -0.14 | 0.04 | -0.02 |
| Free Cash Flow Yield | 0.36% | -0.33% | -36.15% | -9.29% | -3.68% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.20 | -44.82 | -2.73 | -8.63 | -42.62 |
| Price-to-Sales (P/S) Ratio | 2.32 | 4.45 | 0.96 | 2.11 | 6.88 |
| Price-to-Book (P/B) Ratio | 1.38 | 2.56 | 0.45 | 1.31 | 4.48 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 274.27 | -301.74 | -2.77 | -10.77 | -27.19 |
| Price-to-Operating Cash Flow Ratio | 94.04 | 38.47 | -6.70 | 48.78 | -383.82 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | 0.62 | 0.18 | -0.18 | -4.12 |
| Enterprise Value Multiple | 57.33 | 26.05 | -17.19 | -175.28 | -55.55 |
| Enterprise Value | 172.95M | 375.00M | 29.11M | 178.08M | 516.54M |
| EV to EBITDA | 57.33 | 26.05 | -17.19 | -175.28 | -55.55 |
| EV to Sales | 2.22 | 4.32 | 0.39 | 1.96 | 6.20 |
| EV to Free Cash Flow | 262.84 | -292.51 | -1.12 | -10.00 | -24.51 |
| EV to Operating Cash Flow | 90.13 | 37.29 | -2.71 | 45.30 | -345.98 |
| Tangible Book Value Per Share | 0.14 | 0.34 | 0.41 | 0.16 | -0.18 |
| Shareholders’ Equity Per Share | 1.67 | 1.93 | 2.43 | 3.09 | 3.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.04 | 0.01 | 0.05 | -0.01 |
| Revenue Per Share | 0.99 | 1.11 | 1.14 | 1.92 | 2.01 |
| Net Income Per Share | -0.25 | -0.11 | -0.40 | -0.47 | -0.32 |
| Tax Burden | 0.98 | 0.96 | 0.99 | 0.95 | 1.01 |
| Interest Burden | 1.18 | 0.93 | 1.01 | 1.06 | 1.02 |
| Research & Development to Revenue | 0.35 | 0.31 | 0.43 | 0.38 | 0.34 |
| SG&A to Revenue | 0.60 | 0.54 | 0.19 | 0.19 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.10 | -1.07 | 0.41 | -0.20 | 0.11 |
Currency in SEK
